Results 151 to 160 of about 43,386 (236)

Tolvaptan in patients with autosomal dominant polycystic kidney disease.

New England Journal of Medicine, 2012
V. Torres, A. Chapman, O. Devuyst, R. Gansevoort, J. Grantham, E. Higashihara, R. Perrone, H. Krasa, J. Ouyang, F. Czerwiec   +9 more
semanticscholar   +1 more source

Tolvaptan in Later‐Stage Autosomal Dominant Polycystic Kidney Disease

New England Journal of Medicine, 2017
V. Torres, A. Chapman, O. Devuyst, R. Gansevoort, R. Perrone, G. Koch, J. Ouyang, R. Mcquade, J. Blais, F. Czerwiec, O. Sergeyeva   +10 more
semanticscholar   +1 more source

Tratamiento quirúrgico de la enfermedad poliquística hepática autosómica dominante, serie de casos

Revista Colombiana de Cirugía
Nowadays liver and biliary tract surgery are the most commonly performed procedures worldwide; refinement in surgical techniques, anesthetic care and liver transplantation have revolutionized the treatment of liver diseases that were previously incurable.
Andrés Ayala, Juan Carlos Aguilar, Fernando Jiménez, Frans Serpa   +3 more
doaj  

Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment

International Journal of Nephrology and Renovascular Disease, 2010
Christian R Halvorson1, Matthew S Bremmer1, Stephen C Jacobs11Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USAAbstract: Both autosomal dominant and recessive polycystic kidney disease are conditions with severe ...
Christian R Halvorson, Matthew S Bremmer, Stephen C Jacobs   +2 more
doaj  

The Prevalence, Mechanisms, and Clinical Significance of Inferior Vena Cava Compression in Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study Based on TriNetX. [PDF]

Medicina (Kaunas)
Matarneh A, Matarneh B, Akkari A, Sardar S, Salameh O, Verma N, Ghahramani N.   +6 more
europepmc   +1 more source

RETRACTED: Kebede et al. Determinants of Disease Progression in Autosomal Dominant Polycystic Kidney Disease. <i>J. Pers. Med.</i> 2024, <i>14</i>, 936. [PDF]

J Pers Med
Kebede MA, Mengistu YT, Loge BY, Eshetu MA, Shash EP, Wirtu AT, Gemechu JM.   +6 more
europepmc   +1 more source

Correction: Scarlat et al. Autosomal Dominant Polycystic Kidney Disease: From Pathogenesis to Organoid Disease Models. <i>Biomedicines</i> 2025, <i>13</i>, 1766. [PDF]

Biomedicines
Scarlat A, Tomasoni S, Trionfini P.
europepmc   +1 more source

Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.

Journal of the American Society of Nephrology, 2017
E. Cornec-Le Gall, V. Torres, P. Harris
semanticscholar   +1 more source

Trajectories of Kidney Function in Autosomal Dominant Polycystic Kidney Disease Patients Treated with Tolvaptan. [PDF]

Medicina (Kaunas)
Jankowska Z, Niemczyk M.
europepmc   +1 more source

Coincidence of autosomal dominant polycystic kidney disease and Alport syndrome: a case report and literature review. [PDF]

CEN Case Rep
Liu R, Liu F.
europepmc   +1 more source